UBS Group’s Advent Technologies ADN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,362
| Closed | -$14.5K | – | 10440 |
|
|
2025
Q3 | $14.5K | Buy |
4,362
+4,286
| +5,639% | +$12.6K | ﹤0.01% | 8363 |
|
|
2025
Q2 | $158 | Buy |
76
+1
| +1% | +$3 | ﹤0.01% | 9952 |
|
|
2025
Q1 | $318 | Sell |
75
-12,923
| -99% | -$66.8K | ﹤0.01% | 9825 |
|
|
2024
Q4 | $65K | Buy |
12,998
+12,923
| +17,231% | +$53.4K | ﹤0.01% | 7138 |
|
|
2024
Q3 | $162 | Hold |
75
| – | – | ﹤0.01% | 9100 |
|
|
2024
Q2 | $229 | Sell |
75
-1,482
| -95% | -$5.82K | ﹤0.01% | 9056 |
|
|
2024
Q1 | $8.41K | Buy |
1,557
+1,481
| +1,949% | +$8.11K | ﹤0.01% | 7334 |
|
|
2023
Q4 | $508 | Sell |
76
-373
| -83% | -$4.3K | ﹤0.01% | 8621 |
|
|
2023
Q3 | $5.27K | Sell |
449
-135
| -23% | -$2.66K | ﹤0.01% | 7382 |
|
|
2023
Q2 | $10.3K | Buy |
584
+42
| +8% | +$1.01K | ﹤0.01% | 7146 |
|
|
2023
Q1 | $17.2K | Sell |
542
-161
| -23% | -$8.12K | ﹤0.01% | 7191 |
|
|
2022
Q4 | $38.2K | Buy |
703
+92
| +15% | +$5.7K | ﹤0.01% | 7015 |
|
|
2022
Q3 | $56K | Sell |
611
-36
| -6% | -$3.21K | ﹤0.01% | 6226 |
|
|
2022
Q2 | $49K | Buy |
647
+115
| +22% | +$6.94K | ﹤0.01% | 5921 |
|
|
2022
Q1 | $37K | Sell |
532
-878
| -62% | -$99.4K | ﹤0.01% | 6782 |
|
|
2021
Q4 | $297K | Buy |
1,410
+1,398
| +11,650% | +$349K | ﹤0.01% | 5371 |
|
|
2021
Q3 | $3K | Buy |
+12
| New | +$2.92K | ﹤0.01% | 8786 |
|
|
2021
Q1 | – | Sell |
-1,735
| Closed | -$777K | – | 8924 |
|
|
2020
Q4 | $777K | Buy |
1,735
+1,547
| +823% | +$535K | ﹤0.01% | 4223 |
|
|
2020
Q3 | $58K | Buy |
188
+154
| +453% | +$47.7K | ﹤0.01% | 5532 |
|
|
2020
Q2 | $10K | Buy |
+34
| New | +$10.4K | ﹤0.01% | 6994 |
|
|
2020
Q1 | – | Sell |
-633
| Closed | -$192K | – | 7910 |
|
|
2019
Q4 | $192K | Buy |
+633
| New | +$191K | ﹤0.01% | 5625 |
|
Other funds holding ADN
UBS Group's ADN Position: Q4 2025 in Review
UBS Group sold out of Advent Technologies (ADN) in Q4 2025, closing a stake of 4,362 shares — an estimated $14.5K sold.
UBS Group first reported a position in ADN in Q4 2019 and held it in 21 quarters. The position peaked at $777K in Q4 2020. 1 fund tracked by Wall St. Rank holds ADN as of Q4 2025.
- UBS Group reported no remaining Advent Technologies position as of Q4 2025 after selling out during the quarter.
- UBS Group sold 4,362 Advent Technologies shares in Q4 2025, an estimated $14.5K.
- UBS Group first reported a position in Advent Technologies in Q4 2019 and held it in 21 quarters.
- UBS Group's Advent Technologies position peaked at $777K in Q4 2020.
- 1 fund tracked by Wall St. Rank held Advent Technologies as of Q4 2025.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.